Discrepant views of oncologists and cancer patients on complementary/alternative medicine

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Mary Ann RichardsonChristina Sanders

Abstract

Complementary/ alternative medicine (CAM) is widely used by patients but rarely discussed with oncologists. To understand reasons for the communication gap, this study compares physicians and patients on perceived reasons for CAM use and nondisclosure of use, reactions of physicians to disclosure, and expectations for CAM. Cross-sectional studies assessed 82 physicians (response 68.3%) and 244 of 374 outpatients (response 65.2%) identified as CAM users at the MD Anderson Cancer Center. Data were summarized by frequency and compared using chi-square tests. Physicians were more likely (p<0.001) than patients to attribute CAM use to hope (chi2=17.7), control (chi2=17.5), incurable disease (chi2=42.8), or a nontoxic approach (chi2=50.9). Both physicians and patients agreed CAM could relieve symptoms/side effects, but physicians were less likely (p<0.001) than patients to expect that CAM improved immunity (chi2=72.2) or quality of life (chi2=17.1), cured disease (chi2=42.5), or prolonged life (chi2=58.4). Physicians and patients responded differently (p<0.005) on reasons for nondisclosure. Physicians believed patients felt CAM discussions were unimportant (chi2=7.9) and physicians would not understand (chi2 =48.1), discontinue treat...Continue Reading

References

May 1, 1992·CA: a Cancer Journal for Clinicians·I J Lerner, B J Kennedy
Jul 1, 1997·Annals of Internal Medicine·D M Eisenberg
Jul 1, 1997·Cancer Treatment Reviews·N I WeijlS Osanto
Jun 3, 1999·The New England Journal of Medicine·H J BursteinJ C Weeks
Aug 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·S H Zeisel, R I Salganik
Jan 6, 2000·Journal of the National Cancer Institute·M M LeeD Eisenberg
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RichardsonS E Singletary
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H BoonT Haines-Kamka
Jul 19, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R W ReesC Smith
Aug 3, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·H KappaufW M Gallmeier
Oct 19, 2000·Journal of Pediatric Hematology/oncology·K M KellyM A Weiner
Jun 30, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R MoschènB Sperner-Unterweger
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingJane C Weeks
Apr 27, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C Bethan PowellI Cohen
May 22, 2002·Archives of Internal Medicine·Lisa Corbin Winslow, Howard Shapiro
Aug 22, 2002·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom
Sep 27, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Taka AshikagaLee Nelson
Dec 3, 2002·Annals of Internal Medicine·Wendy A WeigerDavid M Eisenberg
Jan 8, 2003·Seminars in Oncology·Mary Ann Richardson, Stephen E Straus
Feb 7, 2003·Journal of Pediatric Hematology/oncology·Elizabeth A McCurdyThomas W McLean
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cathy A CharlesSylvia Farrell

❮ Previous
Next ❯

Citations

Jul 5, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lynda G BalneavesB Joyce Davison
May 7, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Manfred HenselAnthony D Ho
Oct 7, 2010·Journal of Cancer Survivorship : Research and Practice·Jun James MaoJay Amsterdam
May 2, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Raquel Gerson-CwilichAlberto Villalobos-Prieto
Apr 9, 2013·Complementary Therapies in Clinical Practice·Amal Al-OmariLuna Zaru
Oct 25, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Jennifer L McQuadeLorenzo Cohen
Mar 9, 2011·Integrative Cancer Therapies·Juliann SaquibJohn P Pierce
Dec 12, 2013·BMC Complementary and Alternative Medicine·Annelie LindbergLena Oxelmark
May 2, 2007·International Seminars in Surgical Oncology : ISSO·Mariama Adams, Andrew Paul Jewell
Aug 6, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Keiko KishimotoNoriko Fukushima
Jun 29, 2006·Journal of Psychosocial Oncology·Joan Framo RunfolaPatricia Sherman
Jun 1, 2008·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Do Yeun KimSoon Nam Lee
Dec 7, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Rafiaa ValjiSunita Vohra
Jul 19, 2013·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Moshe Frenkel, Lorenzo Cohen
Aug 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A TrimbornUNKNOWN Working Group Prevention and Integrative Oncology of the German Cancer Society
Jun 15, 2013·Otolaryngologic Clinics of North America·Jennifer E RosenStephanie L Lee
May 24, 2011·Seminars in Oncology·Anne H BlaesTufia Haddad
Nov 26, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·M LövgrenC Tishelman
Sep 2, 2008·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jennifer M RhodeJ Rebecca Liu
Jul 22, 2008·Hematology/oncology Clinics of North America·Mary L Hardy
Nov 26, 2008·Complementary Therapies in Medicine·Eran Ben-Arye, Moshe Frenkel
Nov 9, 2005·European Journal of Cancer Care·J AdamsA F Young
Aug 3, 2006·European Journal of Cancer Care·S CattC Langridge
Sep 30, 2010·Psycho-oncology·Mateya TrinkausCamilla Zimmermann
Nov 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Hsiu-Ho Wang, Ue-Lin Chung
Jul 18, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Jin Young ChoiYoung Ho Yun
Mar 10, 2015·Current Oncology Reports·Moshe FrenkelKenneth Sapire
Sep 18, 2014·Integrative Cancer Therapies·Valerie LeeAbby B Siegel
Nov 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard T LeeFarr A Curlin
Apr 2, 2010·Integrative Cancer Therapies·Moshe FrenkelLorenzo Cohen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.